SEC Tracker
Get the app

Harmony Biosciences Holdings HRMY

Harmony Biosciences APPOINTS Glenn Reicin as Chief Financial Officer

Form
8-K
Filed
Importance
Routine
  • Reports an executive or board change (5.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Harmony Biosciences Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Ani Pharmaceuticals ANIP public float $1.3B, Jun 30, 2025
  2. Innoviva INVA public float $1.3B, Jun 30, 2025
  3. Arrowhead Pharmaceuticals ARWR public float $1.4B, Mar 31, 2025, over 18 months old
  4. Mannkind MNKD public float $1.1B, Jun 30, 2025
  5. Ligand Pharmaceuticals LGND public float $1.6B, Jun 30, 2025